Subscribe to our Newsletters !!


    USFDA arranges Alembic Pharma’s Panelav office as VAI

    The US Food and Drug Administration (USFDA) has characterized the Alembic Pharmaceuticals General Oral Solid Formulation Facility situated at Panelav as Voluntary Action Indicated (VAI). Assessment at the said Facility was led by USFDA from ninth March, 2020 to thirteenth March, 2020. VAI implies USFDA acknowledged the Company’s reaction to its perceptions. Portions of ALEMBIC